carbon monoxide has been researched along with Connective Tissue Diseases in 6 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Connective Tissue Diseases: A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Unclassifiable-interstitial lung disease (uILD) represents a heterogeneous collection of pathologies encompassing those fibrosing lung diseases which do not fulfill current diagnostic criteria." | 1.46 | Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices. ( Bartholmai, BJ; Brun, AL; Egashira, R; Hansell, DM; Jacob, J; Karwoski, R; Kokosi, M; Nair, A; Nicholson, AG; Rajagopalan, S; Walsh, SLF; Wells, AU, 2017) |
| "In very severe interstitial lung disease associated with connective tissue disease (CTD-ILD), progressing despite maximal conventional immunosuppression, there is no effective medical rescue therapy." | 1.38 | Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy. ( Denton, CP; Hansell, DM; Keir, GJ; Maher, TM; Ong, VH; Renzoni, EA; Singh, S; Wells, AU, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacob, J | 1 |
| Bartholmai, BJ | 1 |
| Rajagopalan, S | 1 |
| Egashira, R | 1 |
| Brun, AL | 1 |
| Kokosi, M | 1 |
| Nair, A | 1 |
| Walsh, SLF | 1 |
| Karwoski, R | 1 |
| Nicholson, AG | 1 |
| Hansell, DM | 2 |
| Wells, AU | 2 |
| Öztürk, A | 1 |
| Kayacan, O | 1 |
| Chartrand, S | 1 |
| Swigris, JJ | 1 |
| Stanchev, L | 1 |
| Lee, JS | 1 |
| Brown, KK | 1 |
| Fischer, A | 1 |
| Funauchi, M | 1 |
| Kishimoto, K | 1 |
| Kinoshita, K | 1 |
| Keir, GJ | 1 |
| Maher, TM | 1 |
| Denton, CP | 1 |
| Ong, VH | 1 |
| Singh, S | 1 |
| Renzoni, EA | 1 |
| Zheng, J | 1 |
| Pan, M | 1 |
| Ding, X | 1 |
| Deng, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double Blind Controlled Trial Comparing Rituximab Against Intravenous Cyclophosphamide in Connective Tissue Disease Associated Interstitial Lung Disease[NCT01862926] | Phase 2/Phase 3 | 104 participants (Actual) | Interventional | 2014-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for carbon monoxide and Connective Tissue Diseases
| Article | Year |
|---|---|
[Early diagnosis of connective tissue disease-related pulmonary hypertension].
Topics: Biomarkers; Carbon Monoxide; Chronic Disease; Connective Tissue Diseases; Early Diagnosis; Echocardi | 2009 |
5 other studies available for carbon monoxide and Connective Tissue Diseases
| Article | Year |
|---|---|
Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices.
Topics: Aged; Bronchiectasis; Carbon Monoxide; Connective Tissue Diseases; Female; Forced Expiratory Volume; | 2017 |
Rising stars of DPLD survival: FVC and exercise desaturation (a single-center study)
Topics: Age Factors; Aged; Blood Pressure; Carbon Monoxide; Connective Tissue Diseases; Exercise; Exercise T | 2018 |
Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience.
Topics: Adrenal Cortex Hormones; Adult; Amino Acyl-tRNA Synthetases; Antibodies, Antinuclear; Autoimmune Dis | 2016 |
Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Carbon Monoxide; Connective Tissue Diseases; Female; | 2012 |
Diagnosis of interstitial lung disease in patients with connective tissue disease by the diffusing capacity of carbon monoxide.
Topics: Carbon Monoxide; Connective Tissue Diseases; Humans; Lung Diseases, Interstitial; Radiography, Thora | 2002 |